- Home
- CMPS
as 07-26-2024 4:00pm EST
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Upcoming Earnings Alert:
Get ready for potential market movements as COMPASS Pathways Plc American Depository Shares CMPS prepares to release earnings report on 01 Aug 2024.
| Founded: | N/A | Country: | United Kingdom |
| Employees: | N/A | City: | CHESIRE |
| Market Cap: | 406.9M | IPO Year: | 2020 |
| Target Price: | $42.57 | AVG Volume (30 days): | 350.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.01 - $12.75 | Next Earning Date: | 08-01-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of COMPASS Pathways Plc American Depository Shares (CMPS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Goldsmith George Jay | CMPS | 10% Owner | May 20 '24 | Sell | $7.91 | 8,900 | $70,379.42 | 3,929,413 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 20 '24 | Sell | $7.91 | 8,900 | $70,379.42 | 3,931,687 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 20 '24 | Sell | $7.89 | 6,704 | $52,907.97 | 3,938,313 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 20 '24 | Sell | $7.89 | 6,703 | $52,900.08 | 3,940,587 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 20 '24 | Sell | $7.89 | 6,704 | $52,907.97 | 3,938,313 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 20 '24 | Sell | $7.89 | 6,703 | $52,900.08 | 3,940,587 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 20 '24 | Sell | $7.91 | 8,900 | $70,379.42 | 3,929,413 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 20 '24 | Sell | $7.91 | 8,900 | $70,379.42 | 3,931,687 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 2 '24 | Sell | $8.82 | 18,762 | $165,456.45 | 3,947,290 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 2 '24 | Sell | $8.82 | 18,761 | $165,447.63 | 3,945,017 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 2 '24 | Sell | $8.29 | 9,621 | $79,760.01 | 3,966,052 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | May 2 '24 | Sell | $8.29 | 9,622 | $79,768.30 | 3,963,778 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 2 '24 | Sell | $8.29 | 9,621 | $79,760.01 | 3,966,052 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 2 '24 | Sell | $8.29 | 9,622 | $79,768.30 | 3,963,778 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 2 '24 | Sell | $8.82 | 18,762 | $165,456.45 | 3,947,290 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | May 2 '24 | Sell | $8.82 | 18,761 | $165,447.63 | 3,945,017 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.78 | 10,850 | $95,307.49 | 3,975,673 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.78 | 10,850 | $95,307.49 | 3,973,400 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.53 | 23,881 | $203,678.66 | 3,986,523 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.53 | 23,880 | $203,670.13 | 3,984,250 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.53 | 23,880 | $203,670.13 | 3,984,250 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.78 | 10,850 | $95,307.49 | 3,975,673 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.78 | 10,850 | $95,307.49 | 3,973,400 | SEC Form 4 |
| Goldsmith George Jay | CMPS | 10% Owner | Apr 16 '24 | Sell | $8.53 | 23,881 | $203,678.66 | 3,986,523 | SEC Form 4 |
| Malievskaia Ekaterina | CMPS | 10% Owner | Apr 1 '24 | Sell | $8.96 | 25,750 | $230,665.93 | 4,010,404 | SEC Form 4 |
Latest COMPASS Pathways Plc American Depository Shares News
CMPS Breaking Stock News: Dive into CMPS Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Compass Pathways to announce second quarter financial results on August 1, 2024
GlobeNewswire
a month ago
Compass Pathways appoints Lori Englebert as Chief Commercial Officer
GlobeNewswire
a month ago
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Motley Fool
a month ago
Should You Buy the Dip on Compass Pathways Stock?
Motley Fool
2 months ago
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Washington Post
2 months ago
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
The Wall Street Journal
2 months ago
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
Motley Fool
2 months ago
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Compare CMPS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CMPS COMPASS Pathways Plc American Depository Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.